Mirae Asset Global ETFs Holdings
BCAX

Mirae Asset Global ETFs Holdings’s Bicara Therapeutics BCAX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$349K Sell
17,666
-474
-3% -$8.16K ﹤0.01% 2070
2025
Q4 		$303K Buy
18,140
+2,030
+13% +$34.7K ﹤0.01% 2151
2025
Q3 		$254K Sell
16,110
-2,619
-14% -$29.3K ﹤0.01% 2199
2025
Q2 		$174K Buy
18,729
+7,354
+65% +$87.6K ﹤0.01% 2354
2025
Q1 		$148K Buy
11,375
+468
+4% +$6.21K ﹤0.01% 2465
2024
Q4 		$190K Buy
+10,907
New +$227K ﹤0.01% 2407

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BCAX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Bicara Therapeutics (BCAX) stake by 2.6% in Q1 2026, selling an estimated $8.16K and leaving 17,666 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #2070.

Mirae Asset Global ETFs Holdings first reported a position in BCAX in Q4 2024 and has held it in 6 quarters since. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 17,666 shares of Bicara Therapeutics worth $349K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 474 Bicara Therapeutics shares in Q1 2026, an estimated $8.16K.
  • Bicara Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2070 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.